| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/07/2001 | WO2001039784A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | WO2001039782A1 Radioprotecting agent |
| 06/07/2001 | WO2001039781A1 Pharmaceutical combinations |
| 06/07/2001 | WO2001039780A1 Activation of novel estrogen receptor supports neuronal viability and function |
| 06/07/2001 | WO2001039779A1 A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders |
| 06/07/2001 | WO2001039778A2 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
| 06/07/2001 | WO2001039777A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | WO2001039776A1 Combination of an ergoline and riluzole for preventing and treating motor neuron diseases |
| 06/07/2001 | WO2001039775A1 Benzimidazole compounds having nociceptin receptor affinity |
| 06/07/2001 | WO2001039774A1 Topical administration of ketotifen |
| 06/07/2001 | WO2001039773A1 Thrombopoietin mimetics |
| 06/07/2001 | WO2001039772A1 Pharmaceutical formulations containing zolmitriptan |
| 06/07/2001 | WO2001039771A1 Use of melatonin for treating androgenetic and diffuse alopecia |
| 06/07/2001 | WO2001039770A1 USE OF HMG-CoA REDUCTASE INHIBITORS FOR TREATING SEBORRHEA |
| 06/07/2001 | WO2001039769A1 Hypoglycemics comprising organic zinc (ii) complexes |
| 06/07/2001 | WO2001039767A1 Tertiary amino compounds having opioid receptor affinity |
| 06/07/2001 | WO2001039766A2 Screening invertebrate pheromones for therapeutic activity |
| 06/07/2001 | WO2001039765A2 Compositions and methods for the induction and treatment of retinal detachments |
| 06/07/2001 | WO2001039764A2 Methods for treating conditions and illnesses associated with abnormal vasculature |
| 06/07/2001 | WO2001039763A2 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors |
| 06/07/2001 | WO2001039762A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system |
| 06/07/2001 | WO2001039761A1 Administration of an alpha-2 adrenergic receptor agonist to enhance cardiopulmonary resuscitation |
| 06/07/2001 | WO2001039760A2 Method of treating batten disease |
| 06/07/2001 | WO2001039759A2 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 06/07/2001 | WO2001039757A2 Surfactants as malarial chloroquine resistance reversal agents |
| 06/07/2001 | WO2001039754A1 Transdermal device comprising a reservoir and a matrix containing the same active principle |
| 06/07/2001 | WO2001039753A1 Transdermal therapeutic systems with improved stability and a method for the production thereof |
| 06/07/2001 | WO2001039750A1 Effervescent histamine h2 antagonist composition |
| 06/07/2001 | WO2001039747A2 Cassette-shaped constructional units in a rotary printing machine |
| 06/07/2001 | WO2001039745A2 Aerosol composition comprising formoterol |
| 06/07/2001 | WO2001039742A2 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 06/07/2001 | WO2001039741A2 Mitomycin c solution |
| 06/07/2001 | WO2001039739A1 Retinaldehyde combination with antifungal activity |
| 06/07/2001 | WO2001039738A2 Use of flavones and/or isoflavones from plant extracts |
| 06/07/2001 | WO2001039724A2 Phosphonate compounds |
| 06/07/2001 | WO2001039723A2 Triazospiro compounds having nociceptin receptor affinity |
| 06/07/2001 | WO2001039720A2 Dna polymerase inhibitors, mikanolide and dihydromikanolide |
| 06/07/2001 | WO2001039656A2 Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia |
| 06/07/2001 | WO2001039608A1 Addition of tetracyclines to animal foodstuffs |
| 06/07/2001 | WO2001039582A1 Use of a buffer to prevent candida albicans infections on the skin |
| 06/07/2001 | WO2001039573A2 Novel use of lung surfactant for treating legionnaire's disease |
| 06/07/2001 | WO2001028557B1 Cannabimimetic indole derivatives |
| 06/07/2001 | WO2001025213A3 Pyrrolo imidazole derivatives and their use as medicaments |
| 06/07/2001 | WO2001023366A3 Vasopressin antagonist and diuretic combination |
| 06/07/2001 | WO2001018028A8 Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds for inhibiting oestrone sulfatase |
| 06/07/2001 | WO2001015654A3 Low molecular weight antithrombotic polysaccharide |
| 06/07/2001 | WO2001015553B1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 06/07/2001 | WO2001013780A3 Apparatus and method for anesthetizing the cervical region of a female |
| 06/07/2001 | WO2001012187A3 Benzoic acid derivatives and their use as ppar receptor agonists |
| 06/07/2001 | WO2001011971B1 Natural, anti-bacterial, anti-inflammation, anti-virus, anti-herpes cream |
| 06/07/2001 | WO2001010902A3 Nucleoc acids and secreted polypeptides encoded thereby |
| 06/07/2001 | WO2001010894A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 06/07/2001 | WO2001008667A3 2-aminotetralin derivatives for the therapy of glaucoma |
| 06/07/2001 | WO2001000192A3 Method of administering an imidazole derivative to obtain analgesia |
| 06/07/2001 | WO2000072823A8 Preparations for the application of anti-inflammatory agents |
| 06/07/2001 | WO2000069424A3 Method of treating psychotic disorders |
| 06/07/2001 | WO2000064424A3 Cystic fibrosis medicaments |
| 06/07/2001 | WO2000030629A3 Method of promoting cervical and vaginal secretions |
| 06/07/2001 | WO2000023126A3 Methods for treating superficial bladder carcinoma |
| 06/07/2001 | WO2000000184A8 Use of histamine h2 mimicking substances for the treatment of multiple sclerosis |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/07/2001 | WO1999052548A9 Conjugate vaccines for the prevention of dental caries |
| 06/07/2001 | US20010003121 Adamantane derivatives such as 2,4-dichloro-N-(tricyclo(3.3.1.13,7)dec-1-methyl)-benzamide; administering to treat rheumatoid arthritis; immunosuppressant |
| 06/07/2001 | US20010003120 Method for treating erectile dysfunction |
| 06/07/2001 | US20010003119 Edible, wholly or partially nondigestible low calorie fatty acid polyesters having non-Newtonian pseudoplastic rheology at body temperature; substitute for triglyceride fats in low calorie fat-containing foods; for reducing serum cholesterol |
| 06/07/2001 | US20010003002 As dietary supplement, for treating osteoporosis |
| 06/07/2001 | US20010003001 Compounds and compositions for delivering active agents |
| 06/07/2001 | US20010002999 For oral administration comprising an analgesic with rapid onset of action and at least one systemically acting analgesic with sustained action, such as a combination of benzocaine and acetylsalicylic acid (ASA) |
| 06/07/2001 | DE19958684A1 Verwendung von GD3-Synthase-Inhibitoren zur Behandlung neuropathologischer Störungen und Verfahren zur Identifizierung von GD3-Synthase-Inhibitoren Use of GD3 synthase inhibitors for the treatment of neuropathological disorders, and to methods for identifying the GD3 synthase inhibitors |
| 06/07/2001 | DE19958460A1 Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation Process for preparing epinastine hydrochloride in the high-melting crystal modification |
| 06/07/2001 | DE19958388A1 Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten Triazinone compounds for the treatment of diseases caused by infestation with parasitic protozoa |
| 06/07/2001 | DE19958153A1 Oxazolidinon-Derivate Oxazolidinone derivatives |
| 06/07/2001 | DE19956772A1 Verwendung von y-Butyrobetain Salzen zur Herstellung von Zubereitungen für die menschliche und tierische Ernährung Use of y-butyrobetaine salts for the production of preparations for human and animal nutrition |
| 06/07/2001 | DE19955607A1 Medikament oder aufeinander abgestimmte Kombination von Medikamenten Drug or combination of drugs concerted |
| 06/07/2001 | DE19952146A1 Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Arylalkanes, aryl alkenes and aryl azaalkane, pharmaceutical compositions containing them and methods for their preparation |
| 06/07/2001 | DE19948434A1 Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amine |
| 06/07/2001 | CA2747954A1 Phosphonate compounds |
| 06/07/2001 | CA2696185A1 Use of taurolidine and derivatives thereof in the treatment of cancer by induction of apoptosis |
| 06/07/2001 | CA2475026A1 A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders |
| 06/07/2001 | CA2398927A1 Administration of an alpha-2 adrenergic receptor agonist to enhance cardiopulmonary resuscitation |
| 06/07/2001 | CA2395094A1 Acryloyl peptidic derivatives, process for their preparation and their use as antitumor agents |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2394142A1 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 06/07/2001 | CA2393610A1 Transition metal-cyclopentadienyl-tropane conjugates |
| 06/07/2001 | CA2393440A1 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 06/07/2001 | CA2393265A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| 06/07/2001 | CA2393252A1 Use of methylol-containing compounds to treat tumors |
| 06/07/2001 | CA2393233A1 Carbon dioxide enhancement of inhalation therapy |
| 06/07/2001 | CA2393217A1 Oxazolidinone derivatives |
| 06/07/2001 | CA2393193A1 Radiation protecting agent |
| 06/07/2001 | CA2393190A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 06/07/2001 | CA2393179A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | CA2393056A1 New dna polymerase inhibitors, mikanolide and dihydromikanolide |
| 06/07/2001 | CA2393047A1 6-o-methylerythromycin a crystal form iii |
| 06/07/2001 | CA2393041A1 Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds |
| 06/07/2001 | CA2393026A1 Bryostatin analogues, synthetic methods and uses |
| 06/07/2001 | CA2392993A1 Agent for improving learning and/or memory |
| 06/07/2001 | CA2392989A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| 06/07/2001 | CA2392979A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline crystal |
| 06/07/2001 | CA2392958A1 Methods and compositions for regulating lymphocyte activity |